A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy

Condition:   Leprosy, Multibacillary Intervention:   Drug: Bedaquiline 200 mg Sponsor:   Janssen Research & Development, LLC Not yet recruiting

Source: ClinicalTrials.gov - December 27, 2017 Category: Research Source Type: clinical trials